Figure Acquisition Corp. I - Quarter Report: 2021 September (Form 10-Q)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
☒ |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
For the quarterly period ended September 30, 2021
OR
☐ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
For the transition period from to .
FIGURE ACQUISITION CORP. I
(Exact name of registrant as specified in its charter)
Delaware
|
001-40081
|
85-4326385
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(I.R.S. Employer Identification Number)
|
650 California Street, Suite 2700
San Francisco, CA 94108
(Address of principal executive offices, including zip code)
(628) 210-6937
Registrant’s Telephone Number, Including Area Code
Not Applicable
(Former name or former address, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
||
Class A common stock, par value $0.01 per share
|
FACA
|
The New York Stock Exchange
|
||
Redeemable warrants, each one whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
|
FACA WS
|
The New York Stock Exchange
|
||
Units, each consisting of one share of Class A common stock and one-fourth of one redeemable warrant
|
FACA.U
|
The New York Stock Exchange
|
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such
shorter period that the registrant was required to submit such files).Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated
filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer ☐
|
Accelerated filer ☐
|
Non-accelerated filer ☒
|
Smaller reporting company ☒
|
Emerging growth company ☒
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐
As of November 22, 2021, 28,750,000 shares of Class A common stock, par value $0.0001 per share, 3,194,444 shares of Class B common stock, par value $0.0001 per share, and 9,126,984 shares of Class L common stock, par value $0.0001, were issued and outstanding, respectively.
FIGURE ACQUISITION CORP. I
Form 10-Q
For the Quarter Ended September 30, 2021
Page
|
|
1
|
|
1
|
|
1
|
|
2
|
|
3
|
|
4
|
|
5
|
|
19 | |
22 |
|
22 |
|
22 |
|
22 |
|
23 | |
23 | |
23 | |
23 | |
23 | |
24 |
FIGURE ACQUISITION CORP. I
September 30,
2021
|
December 31,
2020
|
|||||||
(unaudited)
|
(audited)
|
|||||||
Assets:
|
||||||||
Current assets:
|
||||||||
Cash
|
$
|
853,737
|
$
|
25,000
|
||||
Prepaid Expenses
|
308,523
|
—
|
||||||
Total current assets
|
1,162,260
|
25,000
|
||||||
Deferred offering costs
|
—
|
49,366
|
||||||
Cash and securities held in Trust Account
|
287,524,019
|
—
|
||||||
Other non-current assets
|
114,671 | — | ||||||
Total Assets
|
$
|
288,800,950
|
$
|
74,366
|
||||
Liabilities and Stockholders’ Equity
|
||||||||
Current liabilities:
|
||||||||
Accrued offering costs and expenses
|
$
|
189,769
|
$
|
57,500
|
||||
Due to related party
|
—
|
—
|
||||||
Total current liabilities
|
189,769
|
57,500
|
||||||
Deferred underwriting fee
|
10,062,500
|
—
|
||||||
Warrant liability
|
12,971,875
|
—
|
||||||
Total liabilities
|
23,224,144
|
57,500
|
||||||
Commitments and Contingencies (See Note 6) | ||||||||
Class A Common Stock subject to possible redemption, 28,750,000 and 0 shares at redemption value, at September 30, 2021 and December 31, 2020, respectively
|
287,524,019
|
—
|
||||||
Stockholders’ Equity:
|
||||||||
Preferred stock, $0.0001 par value; 1,000,000 shares authorized;none
issued and outstanding
|
—
|
—
|
||||||
Class A common stock, $0.01 par value; 100,000,000 shares authorized; no
shares issued and outstanding (excluding 28,750,000 and no shares subject to possible redemption) at September 30, 2021
and December 31, 2020, respectively
|
—
|
—
|
||||||
Class B common stock, $0.0001 par value; 10,000,000 shares authorized; 3,194,444
shares issued and outstanding at September 30, 2021 and December 31, 2020
|
319
|
319
|
||||||
Class L common stock, $0.0001 par value; 15,000,000 shares authorized; 9,126,984
shares issued and outstanding at September 30, 2021 and December 31, 2020
|
913
|
913
|
||||||
Additional paid-in capital
|
—
|
23,768
|
||||||
Retained earnings (accumulated deficit)
|
(21,948,445
|
)
|
(8,134
|
)
|
||||
Total stockholders’ equity
|
(21,947,213
|
)
|
16,866
|
|||||
Total Liabilities and Stockholders’ Equity
|
$
|
288,800,950
|
$
|
74,366
|
The accompanying notes are an integral part of these financial statements.
FIGURE ACQUISITION CORP. I
FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2021
(UNAUDITED)
For the three
months ended
September 30, 2021
|
For the nine
months ended
September 30, 2021
|
|||||||
Formation and operating costs
|
$
|
169,986
|
$
|
489,192
|
||||
Loss from Operations
|
(169,986
|
)
|
(489,192
|
)
|
||||
Other income (loss):
|
||||||||
Interest earned on cash and marketable securities held in Trust Account
|
20,526
|
24,018
|
||||||
Offering costs allocated to warrants
|
—
|
(621,678
|
)
|
|||||
Excess
fair value of private warrants in excess of proceeds received |
(155,000 | ) | (155,000 | ) | ||||
Change in fair value of warrant liability
|
4,231,875
|
5,930,000
|
||||||
Total other income (loss)
|
4,097,401
|
5,177,340
|
||||||
Net income
|
$
|
3,927,415
|
$
|
4,688,148
|
||||
Weighted average shares outstanding, Class A common stock subject to possible redemption
|
28,750,000
|
23,168,498
|
||||||
Basic and diluted net income per share, Class A common stock subject to possible redemption
|
$
|
0.10
|
$
|
0.13
|
||||
Weighted average shares outstanding, Non-redeemable Class B and Class L common stock
|
12,321,428
|
12,009,419
|
||||||
Basic and diluted net income per share, Non-redeemable Class B and Class L common stock
|
$
|
0.10
|
$
|
0.13
|
The accompanying notes are an integral part of these financial statements.
FIGURE ACQUISITION
CORP. I
FOR THE THREE AND NINE
MONTHS ENDED SEPTEMBER 30, 2021
(UNAUDITED)
Class A
Common stock
|
Class B
Common stock
|
Class L
Common stock
|
Additional
Paid-in
|
Retained
|
Total
Stockholder’s
|
|||||||||||||||||||||||||||||||
Shares
|
Amount
|
Shares
|
Amount
|
Shares
|
Amount
|
Capital
|
Earnings
|
Equity (Deficit)
|
||||||||||||||||||||||||||||
Balance as of January 1,
2021
|
— |
$ | — | 3,194,444 |
$ | 319 | 9,126,984 |
$ | 913 | $ | 23,768 | $ | (8,134 | ) | $ | 16,866 | ||||||||||||||||||||
Net income (As Restated)
|
— |
— |
— |
— |
— |
— |
— |
1,850,115 |
1,850,115 |
|||||||||||||||||||||||||||
Accretion of Class A common stock subject to possible redemption
|
— |
— |
— |
— |
— |
— |
(23,768 | ) | (26,604,441 | ) | (26,628,209 | ) | ||||||||||||||||||||||||
Balance as of March 31,
2021 (unaudited)
|
— |
$ | — | 3,194,444 |
$ | 319 | 9,126,984 |
$ | 913 | $ | — | $ | (24,762,460 | ) | $ | (24,761,228 | ) | |||||||||||||||||||
Net loss (As Restated)
|
— |
— |
— |
— |
— |
— |
— |
(1,089,382 | ) | (1,089,382 | ) | |||||||||||||||||||||||||
Accretion of Class A
common stock subject
to possible redemption
|
— |
— |
— |
— |
— |
— |
— |
(3,492 | ) | (3,492 | ) | |||||||||||||||||||||||||
Balance as of June 30,
2021 (unaudited)
|
— |
$ | — | 3,194,444 |
$ | 319 | 9,126,984 |
$ | 913 | $ | — | $ | (25,855,334 | ) | $ | (25,854,102 | ) | |||||||||||||||||||
Net income |
— |
— |
— |
— |
— |
— |
— |
3,927,415 |
3,927,415 |
|||||||||||||||||||||||||||
Accretion of Class A common stock subject to possible redemption
|
— |
— |
— |
— |
— |
— |
— |
(20,526 | ) | (20,526 | ) | |||||||||||||||||||||||||
Balance as of September 30, 2021 (unaudited)
|
— |
$ | — | 3,194,444 |
$ | 319 | 9,126,984 |
$ | 913 | $ | — | $ | (21,948,445 | ) | $ | (21,947,213 | ) | |||||||||||||||||||
The accompanying notes are an integral part of these financial statements.
FIGURE ACQUISITION CORP. I
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2021
(UNAUDITED)
Cash flows from operating activities:
|
||||
Net income
|
$
|
4,688,148
|
||
Adjustments to reconcile net income to net cash used in operating activities:
|
||||
Interest earned on marketable securities held in Trust Account
|
(24,018
|
)
|
||
Offering costs allocated to warrants
|
621,678
|
|||
Excess fair value of private warrants in excess of proceeds received
|
155,000 | |||
Change in fair value of warrant liability
|
(5,930,000
|
)
|
||
Changes in operating assets and liabilities:
|
||||
Prepaid expenses
|
(308,523
|
)
|
||
Other non-current assets
|
(114,671 | ) | ||
Accrued expenses
|
181,635
|
|||
Net cash used in operating activities
|
(730,751
|
)
|
||
Cash Flows from Investing Activities:
|
||||
Investment of cash in Trust Account
|
(287,500,000
|
)
|
||
Net cash used in investing activities
|
(287,500,000
|
)
|
||
Cash Flows from Financing Activities:
|
||||
Proceeds from sale of Units, net of underwriting discount
|
281,750,000
|
|||
Proceeds from issuance of Private Placement Warrants
|
7,750,000
|
|||
Proceeds from promissory note – related party
|
115,492
|
|||
Repayment of promissory note – related party
|
(115,492
|
)
|
||
Payment of offering costs
|
(440,512
|
)
|
||
Net cash provided by financing activities
|
289,059,488
|
|||
Net change in cash
|
828,737
|
|||
Cash, beginning of period
|
25,000
|
|||
Cash, end of the period
|
$
|
853,737
|
||
Supplemental disclosure of non-cash financing activities:
|
||||
Initial classification of common stock subject to possible redemption
|
$
|
287,500,000
|
||
Accretion of common stock subject to possible redemption | $ | 24,019 | ||
Initial classification of warrant liability
|
$
|
18,901,875
|
||
Deferred underwriters’ discount payable charged to accumulated deficit
|
$
|
10,062,500
|
The accompanying notes are an integral part of these unaudited financial statements.
FIGURE ACQUISITION CORP. I
Note 1 — Organization and Business Operations
Figure Acquisition Corp. I (the “Company”) is a newly organized blank check
company incorporated as a Delaware corporation on December 15, 2020. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one
or more businesses (“Business Combination”).
As of September 30, 2021, the Company had not commenced any operations. All
activity through September 30, 2021 relates to the Company’s formation and the Initial Public Offering (“IPO”) which is described below, and identifying a target company for a Business Combination. The Company will not generate any operating
revenues until after the completion of a Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering.
The registration statement for the Company’s IPO was declared effective by the
U.S. Securities and Exchange Commission (the “SEC”) on February 18, 2021 (the “Effective Date”). On February 23, 2021, the Company consummated the IPO of 28,750,000 units ((the “Units” and, with respect to the shares of Class A common stock included in the Units sold, the “Public Shares”), which included the full exercise by the underwriters of the over-allotment
option to purchase an additional 3,750,000 Units, at $10.00 per Unit, generating gross proceeds of $287,500,000, which is discussed in Note 4. Each
Unit consists of one share of common stock, and
of one redeemable warrant to purchase one share of Class A common stock at a price of $11.50 per whole share.Simultaneously with the closing of the IPO, the Company consummated the sale of
5,166,667 Private Placement Warrants (the “Private Placement Warrants”), at a price of $1.50 per Private Placement Warrant, in a private placement to Fintech Acquisition LLC, a Delaware limited liability company (the “Sponsor”), generating gross proceeds of $7,750,000, which is discussed in Note 5.
Transaction costs of the IPO amounted to $16,253,012 consisting of $5,750,000 of
underwriting discount, $10,062,500 of deferred underwriting discount, and $440,512 of other offering costs, and of which $621,678 were
allocated to expense associated with the warrant liability.
Following the closing of the IPO on February 23, 2021, $287,500,000 ($10.00 per Unit) from the
net offering proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was placed in a trust account (the “Trust Account”) and invested in U.S. government treasury bills with a maturity of 185 days or less or in
money market funds investing solely in U.S. Treasuries, as determined by the Company, until the earlier of: (a) the completion of the Company’s initial Business Combination, (b) the redemption of any shares of the Company’s Class A common stock
sold in the Proposed Public Offering (the “public shares”) properly submitted in connection with a stockholder vote to amend the Company’s amended and restated certificate of incorporation (i) to modify the substance or timing of the Company’s
obligation to provide for the redemption of the public shares in connection with the initial Business Combination or to redeem 100% of
the Company’s public shares if it does not complete its initial Business Combination within 24 months from the closing of the Proposed
Public Offering or (ii) with respect to any other provision relating to stockholders’ rights or pre-initial Business Combination activity, and (c) the redemption of 100% of the Company’s public shares if the Company is unable to complete the initial Business Combination within 24
months from the closing of the Public Offering, subject to applicable law.
The Company will provide its
public stockholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial Business Combination either (i) in connection with a stockholder meeting called to approve the initial Business
Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a proposed initial Business Combination or conduct a tender offer will be made by the Company, solely in its discretion.
The stockholders will be entitled to redeem their shares for a pro rata share of the aggregate amount then on deposit in the Trust Account (initially approximately $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations).
The Company will have 24 months from February 23, 2021, the closing of the Public Offering, to complete an initial Business Combination (the “Combination Period”).
However, if the Company is unable to complete its initial Business Combination within the Combination Period, the Company will: (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more
than business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount
then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account and not previously released to the Company to pay its taxes (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish public stockholders’
rights as stockholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining stockholders and board
of directors, liquidate and dissolve, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law.
The Sponsor, officers and
directors have agreed to (i) waive their redemption rights with respect to their shares of the Company’s Class B common stock (the “founder shares”), shares of Class L common stock and public shares in connection with the completion of the
initial Business Combination, (ii) waive their redemption rights with respect to their founder shares, shares of Class L common stock and public shares in connection with a stockholder vote to approve an amendment to the Company’s amended and
restated certificate of incorporation (A) to modify the substance or timing of the Company’s obligation to provide for the redemption of the public shares in connection with an initial Business Combination or to redeem 100% of the public shares if the Company does not complete the initial Business Combination within the Combination Period or (B) with respect to any
other material provisions relating to stockholder’s rights or pre-initial Business Combination activity, (iii) waive their rights to liquidating distributions from the Trust Account with respect to their founder shares and shares of Class L
common stock if the Company fails to complete the initial Business Combination within the Combination Period, and (iv) vote any founder shares held by them and any public shares purchased during or after the Public Offering (including in open
market and privately-negotiated transactions) in favor of the Company’s initial Business Combination.
The Company’s Sponsor has agreed
that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent,
confidentiality or similar agreement or business combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i) $10.00
per public share and (ii) the actual amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a
waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable), nor will it apply to any claims under the Company’s indemnity of the underwriters of the Public Offering against certain
liabilities, including liabilities under the Securities Act. However, the Company has not asked its Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether its Sponsor has sufficient funds to
satisfy its indemnity obligations and believes that the Company’s Sponsor’s only assets are securities of the Company. Therefore, the Company cannot assure that its Sponsor would be able to satisfy those obligations.
Liquidity and Capital Resources
As of September 30, 2021 and December 31, 2020, the Company had approximately
$0.9 million and $25,000
in its operating bank account, and working capital of approximately $1 million and a deficit of $32,500, respectively.
The Company’s liquidity needs up
to February 23, 2021 had been satisfied through a capital contribution from the Sponsor of $25,000 (see Note 6) for the founder
shares and the loan under an unsecured promissory note from the Sponsor of up to $300,000 which was paid in full on February 23,
2021 from the IPO proceeds (see Note 6). Subsequent to the consummation of the IPO,
the Company’s liquidity needs have been satisfied through the net proceeds from the consummation of the Private Placement not held in the Trust Account. In addition, in order to finance transaction costs in connection with a Business
Combination, our Sponsor or an affiliate of our Sponsor, or certain of our officers and directors may, but are not obligated to, provide us working capital loans. As of September 30, 2021 and December 31, 2020, there were no amounts outstanding under any working capital loan.
Based on the foregoing, management believes that the Company will have
sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation of a Business Combination or one year from this filing. Over this time period, we will be using these funds held outside of the Trust
Account for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target
business to merge with or acquire, and structuring, negotiating and consummating the Business Combination.
Risks and Uncertainties
Management is continuing to evaluate the impact of the COVID-19 pandemic and has
concluded that while it is reasonably possible that it could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the
date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Note 2 - Restatement of Previously Issued Financial Statements
In the Company’s
previously issued financial statements, a portion of the public shares were classified as permanent equity to maintain shareholders’ equity greater than $5,000,000 on the basis that the Company will consummate its initial business combination only if the Company has net tangible assets of at least $5,000,001. Thus, the Company can only complete a merger and continue to exist as a public company if there is sufficient Public Shares that do not redeem at the merger and
so it is appropriate to classify the portion of its public shares required to keep its shareholders’ equity above the $5,000,000
threshold as "shares not subject to redemption."
However, in light
of recent comment letters issued by the Securities & Exchange Commission (“SEC”) to several special purpose acquisition companies, management re-evaluated the Company’s application of ASC 480-10-99 to its accounting classification of public
shares. Upon re-evaluation, management determined that the public shares include certain provisions that require classification of the public shares as temporary equity regardless of the minimum net tangible assets required by the Company to
complete its initial business combination.
In connection with
the change in presentation for the Class A common stock subject to possible redemption, the Company also restated its earnings per share calculation to allocate income and losses evenly to Class A and Class B common stock. This presentation
contemplates a Business Combination as the most likely outcome, in which case, both classes of stock share pro rata in the income and losses of the Company.
In accordance with SEC Staff Accounting Bulletin No. 99, “Materiality,” and SEC Staff Accounting Bulletin No. 108, “Considering the Effects of Prior Year
Misstatements when Quantifying Misstatements in Current Year Financial Statements;” the Company evaluated the changes and has determined that the related impacts were material to previously presented financial statements. Therefore, the
Company, in consultation with its Audit Committee, concluded that its previously issued financial statements impacted should be restated to report all public shares as temporary equity. As such the Company is restating those periods in this
Quarterly Report.
The Company also corrected its Delaware franchise tax expense recorded for 2021, which resulted in an additional charge to operating costs and a corresponding
increase in accrued expenses for the three months ended March 31, 2021 and for the three and six months ended June 30, 2021.
Impact of the Restatement
The impact to the Balance Sheets as of February 23, 2021, March 31, 2021 and June 30, 2021, to the Statements of Changes in Stockholders’ Equity for the three
months ended March 31, 2021 and for the three and six months ended June 30, 2021, to the Statements of Operations for the three months ended March 31, 2021 and for the three and six months ended June 30, 2021, and to the Statements of Cash
Flows for the three months ended March 31, 2021 and for the six months ended June 30, 2021 is presented below:
As Previously
Reported
|
Adjustment
|
As Restated | ||||||||||
Balance Sheet as of February 23, 2021 (per form 8-K/A filed on June 4, 2021) | ||||||||||||
Class A common stock subject to possible redemption
|
$
|
255,108,035
|
$
|
32,391,965
|
$
|
287,500,000
|
||||||
Shareholders’ equity (deficit):
|
||||||||||||
Class A common stock, $0.0001
par value
|
32,392
|
(32,392
|
)
|
—
|
||||||||
Additional paid-in capital
|
5,755,132
|
(5,755,132
|
)
|
—
|
||||||||
Retained Earnings (Accumulated Deficit)
|
(788,750
|
)
|
(26,604,441
|
)
|
(27,393,191
|
)
|
||||||
Total shareholders’ equity (deficit)
|
$
|
5,000,006
|
$
|
(32,391,965
|
)
|
$
|
(27,391,959
|
)
|
||||
Shares subject to possible redemption
|
25,510,804
|
3,239,196
|
28,750,000
|
Balance Sheet as of March 31, 2021 (per form 10-Q filed on May 24, 2021) | ||||||||||||
Accrued offering costs and expenses
|
$
|
67,509
|
$
|
19,840
|
$
|
87,349
|
||||||
Total current liabilities
|
67,509
|
19,840
|
87,349
|
|||||||||
Total liabilities
|
26,313,968
|
19,840
|
26,333,808
|
|||||||||
Class A common stock subject to possible redemption
|
257,758,610
|
29,741,390
|
287,500,000
|
|||||||||
Shareholders’ equity (deficit):
|
||||||||||||
Class A common stock, $0.0001
par value
|
29,741
|
(29,741
|
)
|
—
|
||||||||
Additional paid-in capital
|
3,107,208
|
(3,107,208
|
)
|
—
|
||||||||
Retained Earnings (Accumulated Deficit)
|
1,861,821
|
(26,624,281
|
)
|
(24,762,460
|
)
|
|||||||
Total shareholders’ equity (deficit)
|
$
|
5,000,002
|
$
|
(29,761,230
|
)
|
$
|
(24,761,228
|
)
|
||||
Shares subject to possible redemption
|
25,775,861
|
2,974,139
|
28,750,000
|
Balance Sheet as of June 30, 2021 (per form 10-Q filed on August 13, 2021) | ||||||||||||
Accrued offering costs and expenses
|
$
|
104,080
|
$
|
69,703
|
$
|
173,783
|
||||||
Total current liabilities
|
164,441
|
69,703
|
234,144
|
|||||||||
Total liabilities
|
27,275,691
|
69,703
|
27,345,394
|
|||||||||
Class A common stock subject to possible redemption
|
$
|
256,719,090
|
$
|
30,784,402
|
$
|
287,503,492
|
||||||
Shareholders’ equity (deficit):
|
||||||||||||
Class A common stock, $0.0001
par value
|
30,781
|
(30,781
|
)
|
—
|
||||||||
Additional paid-in capital
|
4,145,688
|
(4,145,688
|
)
|
—
|
||||||||
Retained Earnings (Accumulated Deficit)
|
822,302
|
(26,677,636
|
)
|
(25,855,334
|
)
|
|||||||
Total shareholders’ equity (deficit)
|
$
|
5,000,003
|
$
|
(30,854,105
|
)
|
$
|
(25,854,102
|
)
|
||||
Shares subject to possible redemption
|
25,671,909
|
3,078,091
|
28,750,000
|
As Previously
Reported
|
Adjustment | As Restated | ||||||||||
Statement of Changes in Stockholders’ Equity (Deficit) for the three months ended March 31, 2021 (per form 10-Q filed on May 24, 2021) | ||||||||||||
|
||||||||||||
Sale of 28,750,000
Units, net of underwriting discount and offering expenses
|
|
|||||||||||
Class A Common stock - Shares
|
28,750,000 | (28,750,000 | ) | — | ||||||||
Class A Common stock - Amount
|
$ | 287,500 | $ | (287,500 | ) | $ | — | |||||
Additional Paid-in-Capital
|
$ | 271,581,166 | $ | (271,581,166 | ) | $ | — | |||||
Total Stockholders' Equity
|
$ | 271,868,666 | $ | (271,868,666 | ) | $ | — | |||||
Sale of 5,166,667
Private Placement warrants
|
||||||||||||
Additional Paid-in-Capital
|
$ | 7,750,000 | $ | (7,750,000 | ) | $ | — | |||||
Total Stockholders' Equity
|
$ | 7,750,000 | $ | (7,750,000 | ) | $ | — | |||||
Initial classification of warrant liability
|
||||||||||||
Additional Paid-in-Capital
|
$ | (18,746,875 | ) | $ | 18,746,875 | $ | — | |||||
Total Stockholders' Equity
|
$ | (18,746,875 | ) | $ | 18,746,875 | $ | — | |||||
Net income
|
||||||||||||
Retained earnings
|
$ | 1,869,955 | $ | (19,840 | ) | $ | 1,850,115 | |||||
Total Stockholders' Equity
|
$ | 1,869,955 | $ | (19,840 | ) | $ | 1,850,115 | |||||
Class A common stock subject to possible redemption
|
||||||||||||
Class A Common stock - Shares
|
(25,775,861 | ) | 25,775,861 |
— |
||||||||
Class A Common stock - Amount
|
$ | (257,759 | ) | $ | 257,759 | $ | — | |||||
Additional Paid-in-Capital
|
$ | (257,500,851 | ) | $ | 257,500,851 | $ | — | |||||
Total Stockholders' Equity
|
$ | (257,758,610 | ) | $ | 257,758,610 | $ | — | |||||
Accretion of Class A common stock subject to possible redemption
|
||||||||||||
Additional Paid-in-Capital
|
$ | — | $ | (23,768 | ) | $ | (23,768 | ) | ||||
Retained Earnings
|
$ | — | $ | (26,604,441 | ) | $ | (26,604,441 | ) | ||||
Total Stockholders' Equity
|
$ | — | $ | (26,628,209 | ) | $ | (26,628,209 | ) |
Statement of Changes in Stockholders’ Equity (Deficit) for the three and six months ended June 30, 2021 (per form 10-Q filed on August 13, 2021) | ||||||||||||
Period from January 1, 2021 to March 31, 2021 |
||||||||||||
Sale of 28,750,000
Units, net of underwriting discount and offering expenses
|
|
|||||||||||
Class A Common stock - Shares
|
28,750,000 | (28,750,000 | ) | — | ||||||||
Class A Common stock - Amount
|
$ | 287,500 | $ | (287,500 | ) | $ | — | |||||
Additional Paid-in-Capital
|
$ | 271,581,166 | $ | (271,581,166 | ) | $ | — | |||||
Total Stockholders' Equity
|
$ | 271,868,666 | $ | (271,868,666 | ) | $ | — | |||||
Sale of 5,166,667
Private Placement warrants
|
||||||||||||
Additional Paid-in-Capital
|
$ | 7,750,000 | $ | (7,750,000 | ) | $ | — | |||||
Total Stockholders' Equity
|
$ | 7,750,000 | $ | (7,750,000 | ) | $ | — | |||||
Initial classification of warrant liability
|
||||||||||||
Additional Paid-in-Capital
|
$ | (18,746,875 | ) | 18,746,875 | $ | — | ||||||
Total Stockholders' Equity
|
$ | (18,746,875 | ) | $ | 18,746,875 | $ | — | |||||
Net income
|
||||||||||||
Retained earnings
|
$ | 1,869,955 | $ | (19,840 | ) | $ | 1,850,115 | |||||
Total Stockholders' Equity
|
$ | 1,869,955 | $ | (19,840 | ) | $ | 1,850,115 | |||||
Class A common stock subject to possible redemption
|
||||||||||||
Class A Common stock - Shares
|
(25,775,861 | ) | 25,775,861 | — | ||||||||
Class A Common stock - Amount
|
$ | (257,759 | ) | $ | 257,759 | $ | — | |||||
Additional Paid-in-Capital
|
$ | (257,500,851 | ) | $ | 257,500,851 | $ | — | |||||
Total Stockholders' Equity
|
$ | (257,758,610 | ) | $ | 257,758,610 | $ | — | |||||
Accretion of Class A common stock subject to possible redemption
|
||||||||||||
Additional Paid-in-Capital
|
$ | — | $ | (23,768 | ) | $ | (23,768 | ) | ||||
Retained Earnings
|
$ | — | $ | (26,604,441 | ) | $ | (26,604,441 | ) | ||||
Total Stockholders' Equity
|
$ | — | $ | (26,628,209 | ) | $ | (26,628,209 | ) | ||||
Period from April 1, 2021 to June 30, 2021 |
||||||||||||
Net loss
|
||||||||||||
Retained earnings
|
$ | (1,039,519 | ) | $ | (49,863 | ) | $ | (1,089,382 | ) | |||
Total Stockholders' Equity
|
$ | (1,039,519 | ) | $ | (49,863 | ) | $ | (1,089,382 | ) | |||
Change in Class A common stock subject to possible redemption
|
||||||||||||
Class A Common stock - Shares
|
139,952 | (139,952 | ) | — | ||||||||
Class A Common stock - Amount
|
$ | 1,040 | $ | (1,040 | ) | $ | — | |||||
Additional Paid-in-Capital
|
$ | 1,038,480 | $ | (1,038,480 | ) | $ | — | |||||
Total Stockholders' Equity
|
$ | 1,039,520 | $ | (1,039,520 | ) | $ | — | |||||
Accretion of Class A common stock subject to possible redemption
|
||||||||||||
Retained Earnings
|
$ | — | $ | (3,492 | ) | $ | (3,492 | ) | ||||
Total Stockholders' Equity
|
$ | — | $ | (3,492 | ) | $ | (3,492 | ) |
As Previously
Reported
|
Adjustment | As Restated | ||||||||||
Statement of Operations for the three months ended March 31, 2021 (per form 10-Q filed on May 24, 2021) | ||||||||||||
Formation and operating costs
|
$
|
71,283
|
$
|
19,840
|
$
|
91,123
|
||||||
Loss from operations
|
(71,283
|
)
|
(19,840
|
)
|
(91,123
|
)
|
||||||
Net income
|
1,869,955
|
(19,840
|
)
|
1,850,115
|
||||||||
Weighted average shares outstanding, Redeemable Class A common stock
|
25,517,968
|
(13,698,524
|
)
|
11,819,444
|
||||||||
Basic and diluted net income per share, Redeemable Class A common stock
|
$
|
—
|
$
|
0.08
|
$
|
0.08
|
||||||
Weighted average shares outstanding, Non-redeemable common stock
|
12,703,724
|
(1,328,725
|
)
|
11,374,999
|
||||||||
Basic and diluted net loss per shares, Non-redeemable common stock
|
$
|
0.15
|
$
|
(0.07
|
)
|
$
|
0.08
|
Statement of Operations for the three months ended June 30, 2021 (per form 10-Q filed on August 13, 2021) | ||||||||||||
Formation and operating costs
|
$
|
178,220
|
$
|
49,863
|
$
|
228,083
|
||||||
Loss from operations
|
(178,220
|
)
|
(49,863
|
)
|
(228,083
|
)
|
||||||
Net loss
|
(1,039,519
|
)
|
(49,863
|
)
|
(1,089,382
|
)
|
||||||
Weighted average shares outstanding, Redeemable Class A common stock
|
25,774,719
|
2,975,281
|
28,750,000
|
|||||||||
Basic and diluted net income per share, Redeemable Class A common stock
|
$
|
—
|
$
|
(0.03
|
)
|
$
|
(0.03
|
)
|
||||
Weighted average shares outstanding, Non-redeemable common stock
|
15,296,709
|
(2,975,281
|
)
|
12,321,428
|
||||||||
Basic and diluted net loss per shares, Non-redeemable common stock
|
$
|
(0.07
|
)
|
$
|
0.04
|
$
|
(0.03
|
)
|
Statement of Operations for the six months ended June 30, 2021 (per form 10-Q filed on August 13, 2021) | ||||||||||||
Formation and operating costs
|
$
|
249,503
|
$
|
69,703
|
$
|
319,206
|
||||||
Loss from operations
|
(249,503
|
)
|
(69,703
|
)
|
(319,206
|
)
|
||||||
Net income
|
830,436
|
(69,703
|
)
|
760,733
|
||||||||
Weighted average shares outstanding, Redeemable Class A common stock
|
25,700,501
|
(5,369,009
|
)
|
20,331,492
|
||||||||
Basic and diluted net income per share, Redeemable Class A common stock
|
$
|
—
|
$
|
0.02
|
$
|
0.02
|
||||||
Weighted average shares outstanding, Non-redeemable common stock
|
14,007,380
|
(2,156,552
|
)
|
11,850,828
|
||||||||
Basic and diluted net loss per shares, Non-redeemable common stock
|
$
|
0.06
|
$
|
(0.04
|
)
|
$
|
0.02
|
Statement of Cash Flows for the three months ended March 31, 2021 (per form 10-Q filed on May 24, 2021) | ||||||||||||
Cash flows from operating activities:
|
||||||||||||
Net income
|
$
|
1,869,955
|
$
|
(19,840
|
)
|
$
|
1,850,115
|
|||||
Change in operating assets and liabilities:
|
||||||||||||
Accrued expenses
|
26,925
|
19,840
|
46,765
|
|||||||||
Supplemental disclosure of non-cash financing activities:
|
||||||||||||
Initial classification of common stock subject to possible redemption
|
$
|
257,758,610
|
$
|
29,741,390
|
$
|
287,500,000
|
Statement of Cash Flows for the six months ended June 30, 2021 (per form 10-Q filed on August 13, 2021) | ||||||||||||
Cash flows from operating activities:
|
||||||||||||
Net income
|
$
|
830,436
|
$
|
(69,703
|
)
|
$
|
760,733
|
|||||
Change in operating assets and liabilities:
|
||||||||||||
Accrued expenses
|
95,946
|
69,703
|
165,649
|
|||||||||
Supplemental disclosure of non-cash financing activities:
|
||||||||||||
Initial classification of common stock subject to possible redemption
|
$
|
257,758,610
|
$
|
29,741,390
|
$
|
287,500,000
|
||||||
Change in common stock subject to possible redemption
|
(1,039,520
|
)
|
1,039,520
|
—
|
Note 3 — Significant Accounting Policies
Basis of Presentation
The accompanying unaudited condensed financial statements have been prepared in
accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X of the SEC. Certain
information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do
not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all
adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.
The interim results for the nine months ended September 30, 2021 are not
necessarily indicative of the results to be expected for the year ending December 31, 2021 or for any future interim periods.
Emerging Growth Company Status
The Company is an “emerging growth company,” as defined in Section 2(a) of the
Securities Act, as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not
emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its
periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from
being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under
the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging
growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or
private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public
company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates
The preparation of financial statements in conformity with US GAAP requires
management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the
reporting period. Actual results could differ from those estimates.
Cash and Cash Equivalents
The Company considers all short-term investments with an original maturity of
three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of September 30, 2021
and December 31, 2020.
Marketable Securities Held in Trust Account
At September 30, 2021, the assets held in the Trust Account were held in U.S.
Treasury Bills with a maturity of 185 days or less and in money market funds which invest in U.S. Treasury securities. During the nine months ended September 30, 2021, the Company did not withdraw any of the interest income from the Trust Account
to pay its tax obligations.
The Company classifies its United States Treasury securities as held-to-maturity
in accordance with FASB ASC Topic 320 “Investments - Debt and Equity Securities.” Held-to-maturity securities are those securities which the Company has the ability and intent to hold until maturity. Held-to-maturity treasury securities are
recorded at amortized cost and adjusted for the amortization or accretion of premiums or discounts.
A decline in the market value of held-to-maturity securities below cost that is
deemed to be other than temporary, results in an impairment that reduces the carrying costs to such securities’ fair value. The impairment is charged to earnings and a new cost basis for the security is established. To determine whether an
impairment is other than temporary, the Company considers whether it has the ability and intent to hold the investment until a market price recovery and considers whether evidence indicating the cost of the investment is recoverable outweighs
evidence to the contrary. Evidence considered in this assessment includes the reasons for the impairment, the severity and the duration of the impairment, changes in value subsequent to year-end, forecasted performance of the investee, and the
general market condition in the geographic area or industry in which the investee operates.
Premiums and discounts are amortized or accreted over the life of the related
held-to-maturity security as an adjustment to yield using the effective-interest method. Such amortization and accretion are included in the “interest income” line item in the statements of operations. Interest income is recognized when earned.
Warrant Liabilities
The Company evaluated the Public Warrants and Private Placement Warrants
(collectively, “Warrants”, which are discussed in Note 4, Note 5 and Note 9) in accordance with ASC 815-40, “Derivatives and Hedging — Contracts in Entity’s Own Equity”, and concluded that a provision in the Warrant Agreement related to certain
tender or exchange offers precludes the Warrants from being accounted for as components of equity. As the Warrants meet the definition of a derivative as contemplated in ASC 815, the Warrants are recorded as derivative liabilities on the Condensed
Balance Sheet and measured at fair value at inception (on the date of the IPO) and at each reporting date in accordance with ASC 820, “Fair Value Measurement”, with changes in fair value recognized in the Condensed Statement of Operations in the
period of change.
Offering Costs Associated with the Initial Public Offering
The Company complies with the requirements of the ASC 340-10-S99-1. Offering costs consisted of legal,
accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public
Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities are expensed as incurred, presented as non-operating expenses in the statement of operations. Offering costs
associated with the Class A common stock were charged to temporary equity upon the completion of the Initial Public Offering. Transaction costs amounted to $16,253,012, of which $621,678 were allocated to expense associated with the
warrant liability.
Common Stock Subject to Possible Redemption
All of the Class A Common Stock sold as part of the Units in the Public Offering
contain a redemption feature which allows for the redemption of such public shares in connection with the Company’s liquidation, if there is a stockholder vote or tender offer in connection with the Business Combination and in connection with
certain amendments to the Company’s second amended and restated certificate of incorporation. In accordance with SEC and its staff’s guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99, redemption provisions not
solely within the control of the Company require common stock subject to redemption to be classified outside of permanent equity. Ordinary liquidation events, which involve the redemption and liquidation of all of the entity’s equity instruments,
are excluded from the provisions of ASC 480. Accordingly, at September 30, 2021 and December 31, 2020, all shares of Class A common stock subject to possible redemption is presented as temporary equity, outside of the stockholders’ equity section
of the Company’s condensed balance sheet.
The Company recognizes changes in redemption value immediately as they occur and
adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable common stock are affected by charges against additional paid in
capital and accumulated deficit.
Income Taxes
The Company accounts for income taxes under ASC 740 Income Taxes (“ASC 740”). ASC
740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax
loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. The deferred tax assets were deemed to be
de minimis as of September 30, 2021 and December 31, 2020.
ASC 740 also clarifies the accounting for uncertainty in income taxes recognized
in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be
recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and
transition.
The Company recognizes accrued interest and penalties related to unrecognized tax
benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of September 30, 2021 and December 31, 2020. The Company is currently not aware of any issues under review that could
result in significant payments, accruals or material deviation from its position. The Company has identified the United States as its only “major” tax jurisdiction. The Company is subject to income tax examinations by major taxing authorities since
inception. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that
the total amount of unrecognized tax benefits will materially change over the next twelve months. The provision for income taxes was deemed to be de minimis for the period ended September 30, 2021.
Net (Loss) Income Per Common Share
The Company complies with accounting and disclosure requirements of FASB ASC Topic
260, Earnings Per Share. Net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. The Company has two classes of shares, Class A Common Stock and Class B Common
Stock. Earnings and losses are shared pro rata between the two classes of shares. The Company has not considered the effect of warrants sold in the Initial Public Offering and the private placement to purchase 12,354,167 shares of common stock in the calculation of diluted loss per share, since the exercise of the warrants is contingent upon the occurrence of
future events. As a result, diluted net income per common share is the same as basic net income per ordinary share for the period presented.
Basic and diluted net income per common share for Class A common stock and Class B
common stock is calculated by dividing net income attributable to the Company by the weighted average number of shares of Class A common stock and Class B common stock outstanding, allocated proportionally to each class of common stock.
Reconciliation of Net Income per Common Share
The Company’s net income is adjusted for the portion of net income that is
allocable to each class of common stock. The allocable net income is calculated by multiplying net income by the ratio of weighted average number of shares outstanding attributable to Class A and Class B common stock to the total weighted average
number of shares outstanding for the period. Accordingly, basic and diluted income per common share is calculated as follows:
Three Months Ended September 30, 2021
|
Nine Months Ended September 30, 2021
|
|||||||
Redeemable Class A Common Stock
|
||||||||
Net income allocable to Class A Common Stock
|
$
|
2,749,191
|
$
|
3,087,657
|
||||
Basic and diluted weighted average shares outstanding, Class A common stock
|
28,750,000
|
23,168,498
|
||||||
Basic and diluted net income per common share
|
$
|
0.10
|
$
|
0.13
|
||||
Non-Redeemable Class B and Class L Common Stock
|
||||||||
Net income allocable to Non-Redeemable Stock
|
$
|
1,178,224
|
$
|
1,600,491
|
||||
Denominator: Weighted Average Non-Redeemable stock
|
||||||||
Basic and diluted weighted average shares outstanding
|
12,321,428
|
12,009,419
|
||||||
Basic and diluted net income per common share
|
$
|
0.10
|
$
|
0.13
|
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of
credit risk consist of cash accounts in a financial institution, which, at times, may exceed the federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not
exposed to significant risks on such accounts.
Fair Value of Financial Instruments
The fair value of the Company’s assets and liabilities, which qualify as financial
instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.
Recent Accounting Pronouncements
In August 2020, the FASB issued ASU 2020-06, Debt-Debt with Conversion and Other Options (Subtopic
470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”), which simplifies accounting for convertible instruments by
removing major separation models required under current GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for scope exception, and it simplifies the diluted earnings per share
calculation in certain areas. The Company adopted ASU 2020-06 on January 1, 2021. Adoption of the ASU did not impact the Company’s financial position, results of operations or cash flows.
Management does not believe that any other recently issued, but not effective,
accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.
Note 4 — Initial Public
Offering
Public Units
On February 23, 2021, the Company sold 28,750,000 Units, at a purchase price of $10.00
per Unit, which included the full exercise by the underwriters of the over-allotment option to purchase an additional 3,750,000 Units,
at a purchase price of $10.00 per Unit. Each Unit consists of one share of Class A common stock, and
of one redeemable warrant
to purchase one share of Class A common stock (the “Public Warrants”).Public Warrants
Each whole warrant entitles the holder to
purchase one share of the Company’s Class A common stock at a price of $11.50 per share, subject to adjustment as discussed herein. The warrants will become exercisable on the later of 12 months from February 23, 2021, the closing of the Public Offering, or 30
days after the completion of its initial Business Combination, and will expire five years after the completion of the Company’s
initial Business Combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation.
In addition, if (x) the Company issues additional shares of Class A common stock or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective
issue price of less than $9.20 per share of Class A common stock (with such issue price or effective issue price to be determined in
good faith by the Company’s board of directors and, (i) in the case of any such issuance to the Sponsor or any of its respective affiliates, without taking into account any founder shares or shares of Class L common stock held by the Sponsor or
such affiliates, as applicable, prior to such issuance, and (ii) to the extent that such issuance is made to the Sponsor or any of its respective affiliates, without taking into account the transfer of founder shares, shares of Class L common
stock or private placement warrants by the Sponsor in connection with such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination
(net of redemptions), and (z) the volume weighted average trading price of the common stock during the 20 trading day period
starting on the trading day prior to the day on which the Company consummates the initial Business Combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00
per share redemption trigger price described below in “Redemption of warrants when the price per share of Class A common stock equals or exceeds $18.00”
and “Redemption of warrants when the price per share of Class A common stock equals or exceeds $10.00” will be adjusted (to the
nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger described below in “Redemption of warrants when the price per share of Class A common stock equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price.
The Company will not be obligated to deliver any shares of Class A common stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act
with respect to the shares of Class A common stock underlying the warrants is then effective and a prospectus relating thereto is current. No warrant will be exercisable and the Company will not be obligated to issue shares of Class A common
stock upon exercise of a warrant unless Class A common stock issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants.
In no event will the Company be required to net cash settle any warrant. In the event that a registration statement is not effective for the exercised warrants, the purchaser of a unit containing such warrant will have paid the full purchase
price for the unit solely for the share of Class A common stock underlying such unit.
Redemption of Warrants When the Price per
of Class A Common Stock Equals or Exceeds $18.00
Once the warrants become exercisable, the Company may redeem the outstanding warrants:
● |
in whole and not in part;
|
● |
at a price of $0.01 per warrant;
|
● |
upon not
less than 30 days’ prior written notice of redemption (the “30-day redemption period”); and
|
● |
if, and
only if, the last reported sale price of the Class A common stock for any 20 trading days within a 30-trading day period
ending trading days before we send the notice of redemption to the warrant holders (which we refer to as the “Reference Value”) equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like and certain issuances of
Class A common stock and equity-linked securities).
|
The Company will not redeem the warrants
as described above unless a registration statement under the Securities Act covering the issuance of the Class A common stock issuable upon exercise of the warrants is then effective and a current prospectus relating to those Class A common stock
is available throughout the 30-day redemption period. If and when the warrants become redeemable, the Company may exercise its redemption right even if unable to register or qualify the underlying securities for sale under all applicable state
securities laws.
Redemption of Warrants When the Price per
of Class A Common Stock Equals or Exceeds $10.00
Once the warrants become exercisable, the Company may redeem the outstanding warrants:
● |
in whole and not in part;
|
● |
at $0.10 per warrant upon a minimum of 30
days’ prior written notice of redemption, provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by reference to the “fair market value” of the
Class A common stock (as defined below in the immediately following paragraph) except as otherwise described below;
|
● |
if, and
only if, the Reference Value equals or exceeds $10.00 per share (as adjusted per stock splits, stock dividends,
reorganizations, recapitalizations and the like and certain issuances of Class A common stock and equity-linked securities); and
|
● |
if the
Reference Value is less than $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations,
recapitalizations and the like and certain issuances of Class A common stock and equity-linked securities), the private placement warrants must also be concurrently called for redemption on the same terms as the outstanding public
warrants, as described above.
|
The “fair market value” of the Class A
common stock for the above purpose shall mean the volume-weighted average price of the Class A common stock as reported during the
trading days immediately following the date on which the notice of redemption is sent to the holders of warrants. The Company will provide our warrant holders with the final fair market value no later than one business day after the ten-trading
day period described above ends. In no event will the warrants be exercisable in connection with this redemption feature for more than 0.361
shares of Class A common stock per whole warrant (subject to adjustment).If a registration statement covering the shares of Class A common stock issuable upon exercise of the warrants is not effective by the 60th business day after the closing of the initial Business Combination, warrant holders may, until
such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the
Securities Act or another exemption. In such event, each holder would pay the exercise price by surrendering the warrants for that number of shares of Class A common stock equal to the lesser of (A) the quotient obtained by dividing (x) the
product of the number of shares of Class A common stock underlying the warrants, multiplied by the excess of the “fair market value” of the Class A common stock over the exercise price of the warrants by (y) the fair market value and (B) 0.361 per whole warrant. The “fair market value” as used in this paragraph shall mean the average last reported sale price of the Class A common
stock for the ten trading days ending on the third trading day prior to the date on which the notice of exercise is received by the warrant agent. If that exemption, or another exemption, is not available, holders will not be able to exercise
their warrants on a cashless basis.
Note 5 — Private
Placement
Simultaneously with the closing of the IPO, the Sponsor purchased an aggregate of 5,166,667 Private Placement Warrants at a
price of $1.50 per Private Placement Warrant, for an aggregate purchase price of $7,750,000, in a private placement. A portion of the proceeds from the private placement was added to the proceeds from the IPO held in the Trust. The Private Placement Warrants will be non-redeemable in certain circumstances and exercisable on a cashless basis so
long as they are held by the Sponsor or its permitted transferees. Otherwise, the Private Placement Warrants have terms and provisions that are identical to those of the warrants being sold as part of the Units in the Public Offering.
The Private Placement Warrants are identical to the Public Warrants sold in the IPO except that the Private Placement Warrants, so long as they are held by the initial stockholders or its permitted transferees, (i) they will not be
redeemable by the Company for cash, (ii) they (including the Class A common stock issuable upon exercise of these warrants) may not, subject to certain limited exceptions, be transferred, assigned or sold until 30 days after the completion of the Company’s initial Business Combination, and (iii) they may be exercised by the holders on a cashless basis. If
the Private Placement Warrants are held by holders other than the initial purchasers or their permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by the holders on the same basis as the
warrants included in the Units being sold in the IPO.
Note 6 — Related Party
Transactions
Founder Shares
In December 2020, the Company’s Sponsor purchased 4,107,143 shares of Class B common stock and 8,214,286 shares of Class L common stock for a capital contribution of $25,000, or approximately $0.002 per share. In January 2021, the Company’s
Sponsor surrendered its Class B and Class L shares, and the Company reissued to the Sponsor 3,194,444 shares of Class B common stock
(the “founder shares”) and 9,126,984 shares of Class L common stock, with no return of capital or payment by the Sponsor, resulting
in the Sponsor holding 3,194,444 shares of Class B common stock (the “founder shares”) and 9,126,984 shares of Class L common stock, including an aggregate of up to 416,667
shares of Class B common stock and up to 1,190,476 shares of Class L common stock subject to forfeiture, respectively, if the
over-allotment option was not exercised by the underwriters in full. All shares of common stock and
associated amounts have been retroactively restated. As a result of the underwriters’ election to fully exercise their over-allotment option on February 23, 2021, none of the Class B shares or Class L shares are subject to forfeiture any longer.
With certain limited exceptions, the founder shares are not transferable, assignable or saleable (except to the Company’s officers and directors and other persons or entities affiliated with the Sponsor, including their respective
limited partners, each of whom will be subject to the same transfer restrictions) until the earlier of (A) one year after the
completion of the Company’s initial Business Combination or (B) subsequent to the Company’s initial Business Combination, (x) if the reported closing price of Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing
at least 150 days after the Company’s initial Business Combination or (y) the date, following the completion of the Company’s
initial Business Combination, on which the Company completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of the Company’s stockholders having the right to exchange their shares
of common stock for cash, securities or other property.
Promissory Note —
Related Party
On December 22, 2020, Company issued an
unsecured promissory note to the Sponsor for an aggregate of up to $300,000 to cover expenses related to the IPO. This loan was
non-interest bearing and payable on the earlier of September 30, 2021 or the completion of the IPO. During the period from January 1, 2021 to February 23, 2021, the Company had borrowed $115,492 under the promissory note. On February 25, 2021, the Company paid the note balance in full from the proceeds of the IPO, and the note is no longer available to be drawn upon.
Related Party Loans
In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may
be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans
would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay the Working Capital Loans
but no proceeds from the Trust Account would be used to repay the Working Capital Loans. Up to $2,000,000 of such Working Capital
Loans may be convertible into warrants at a price of $1.50 per warrant at the option of the lender. The warrants would be identical
to the Private Placement Warrants, including as to exercise price, exercisability and exercise period. At September 30, 2021 and December 31, 2021, no Working Capital Loans
were outstanding.
Note 7 — Commitments
and Contingencies
Registration Rights
The Sponsor will have rights to require
the Company to register any of its securities held by them for resale under the Securities Act pursuant to a registration and stockholder rights agreement to be signed prior to or on the effective date of the Public Offering. These holders will
be entitled to make up to three demands, excluding short form registration demands, that the Company register such securities for sale
under the Securities Act. In addition, the holders of the founder shares, Private Placement Warrants and warrants that may be issued upon conversion of working capital loans (and any shares of Class A common stock issuable upon the exercise of
the Private Placement Warrants and warrants that may be issued upon conversion of working capital loans and upon conversion of the founder shares) will have certain “piggy-back” registration rights with respect to registration statements filed
subsequent to the completion of the initial Business Combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities Act.
Underwriting Agreement
The underwriter had a 45-day option from the date of the IPO to purchase up to an aggregate of 3,750,000 additional Units at the public offering price less the underwriting commissions to cover over-allotments, if any. On February 23, 2021, the underwriter fully exercised the
over-allotment option, and was paid a fixed underwriting discount of 2% of the gross proceeds of the IPO, or $5,750,000 in aggregate.
The underwriters are entitled to deferred
underwriting fee of 3.5% of the gross proceeds of the IPO, or $10,062,500 in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business
Combination, subject to the terms of the underwriting agreement.
Note 8 — Stockholders’ Equity
Preferred Stock — The Company is authorized to issue 1,000,000 shares of preferred stock with a par value of $0.0001 and with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of
directors. At September 30, 2021 and December 31, 2020, there were no shares of preferred stock issued or outstanding.
Class A Common Stock — The Company is authorized to issue a total of 100,000,000
shares of Class A common stock at par value of $0.01 each. At September 30, 2021 and December 31, 2020, there were no shares issued and outstanding, excluding 28,750,000
and 0 shares subject to possible redemption, respectively.
Class B Common Stock — The Company is authorized to issue a total of 10,000,000
shares of Class B common stock at par value of $0.0001 per share. At September 30, 2021 and December 31, 2020, there were 3,194,444 shares issued and outstanding.
The Company’s sponsor, directors and officers have agreed not to transfer,
assign or sell their founder shares until the earlier to occur of (A) one year after the completion of the Company’s initial Business
Combination or (B) subsequent to the Company’s initial Business Combination, (x) if the reported closing price of the Company’s Class A common stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the Company’s initial Business Combination, or (y) the date on which the Company completes a liquidation, merger, capital stock
exchange, or other similar transaction that results in all of its stockholders having the right to exchange their shares of common stock for cash, securities or other property.
The shares of Class B common stock will automatically convert into shares of the
Company’s Class A common stock at the time of its initial Business Combination on a one-for-one basis, subject to adjustment pursuant
to certain anti-dilution rights, as described herein. In the case that additional shares of Class A common stock or equity-linked securities are issued or deemed issued in connection with the Company’s initial Business Combination, the ratio at
which shares of Class B common stock shall convert into shares of Class A common stock will be adjusted (unless the holders of a majority of the outstanding shares of Class B common stock agree to waive such adjustment with respect to any such
issuance or deemed issuance) so that the number of shares of Class A common stock issuable upon conversion of all shares of Class B common stock will equal, in the aggregate, on an as-converted basis, 10% of the sum of (i) the total number of all shares of common stock outstanding upon the completion of the Public Offering, plus (ii) the total number of shares of Class A
common stock and equity-linked securities issued or deemed issued in connection with or in connection with the initial Business Combination, excluding any shares of Class A common stock or equity-linked securities issued, or to be issued, to any
seller in the initial business combination and any units or warrants issued to our sponsor or its affiliates upon conversion of Working Capital Loans; provided that such conversion of founder shares will never occur on a less than one for one
basis.
Prior to the initial Business Combination, only holders of the Company’s Class B
common stock will have the right to vote on the election of directors. With respect to any other matter submitted to a vote of the Company’s stockholder, holders of record of the Class A common stock and holders of record of the Class B common
stock will vote together as a single class, with each share of common stock entitling the holder to one vote except as required by
law.
Class L Common
Stock —The Company is authorized to issue a total of 15,000,000 shares of Class L common stock at par
value of $0.0001 each. In December 2020, the Company issued 8,214,286 shares of Class L common stock to the Sponsor for approximately $0.002 per share. In January, the Sponsor surrendered its Class L shares and the Company reissued 9,126,984 shares of Class L common stock to the Sponsor with no return of capital or payment by the Sponsor resulting in the Sponsor holding 9,126,984 shares of Class L common stock for approximately $0.002 per share. All shares of common stock and associated amounts have been retroactively restated. At September 30, 2021 and December 31, 2020, there were 9,126,984
shares issued and outstanding.
The Class L common stock shall have no voting rights and will convert into
shares of Class A common stock following the initial Business Combination to the extent certain triggering vesting events occur. The Class L common stock will vest in four equal tranches upon achieving share performance targets. If between the
consummation of our initial business combination and the ten year anniversary of the initial Business Combination the closing price of
the Company's Class A common stock equals or exceeds specified per share trading price targets for any 20 trading days within a 30-trading day period (the four
vesting price targets equal $12.50 ("First Price Vesting"), $15.00 ("Second Price Vesting"), $17.50 ("Third Price Vesting"),
and $20.00 ("Fourth Price Vesting")),
of the Class L common shares will automatically convert into Class A common shares on a 1-for-1 basis. For example, if fifteen months following the consummation of the initial Business Combination the closing price of the shares of Class A common stock equals or
exceeds $15.00 but does not exceed $17.50
for 20 trading days within a 30-trading
day period, both the First Price Vesting and Second Price Vesting target achievements will be met, resulting in a total of 3,968,254
Class L Shares converting into 3,968,254 shares of Class A common stock, representing 1,984,127 shares associated with the First Price Vesting and 1,984,127
shares associated with the Second Price Vesting (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and the like).For purposes of the foregoing price vesting targets, if the Company consummates
any liquidation, merger, share exchange, reorganization or other similar transaction after its initial business combination and before the
anniversary of its initial business combination (a "Strategic Transaction") which results in all of the public stockholders having the right to exchange their common stock for cash, securities or other property, then the Company’s board of
directors will determine in good faith the effective price per share of Class A common stock in such Strategic Transaction. This effective price will dictate how many remaining shares of Class L common stock convert on a one-for-one basis to
shares of Class A common stock, based on the foregoing price vesting targets.For example, if the Company consummates a Strategic Transaction and the First
and Second Price Vesting targets have previously been achieved and the effective price in such Strategic Transaction is determined to be $17.50,
then 1,984,127 shares of Class L common stock will convert at the closing of such Strategic Transaction on a one-for-one basis to 1,984,127 shares of Class
A common stock, and any remaining shares of Class L common stock will be forfeited.
Further, for example, if the Company consummates a Strategic Transaction and the
First and Second Price Vesting targets have previously not been achieved and the effective price in such Strategic Transaction is determined to be $17.50,
then 5,952,381 shares of Class L common stock will convert at the closing of such Strategic Transaction on a one-for-one basis to 5,952,381 shares of Class A common stock, and any remaining shares of Class L common stock will be forfeited.
In contrast, if the Company consummates a Strategic Transaction and the First
and Second Price Vesting targets have previously been achieved and the effective price in such Strategic Transaction is determined to be only $14.00,
then under the Strategic Transaction threshold, no shares of Class L common stock will convert because no additional price vesting target has been achieved; thus, none of the remaining shares of Class L common stock will convert to shares of Class A common stock at the closing of such Strategic Transaction, and any remaining shares of Class L common stock will be
forfeited.
Note 9 — Fair Value Measurements
The Company follows the guidance in ASC 820 for its financial assets and
liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually.
The fair value of the Company’s financial assets and liabilities reflects
management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement
date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal
assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets
and liabilities:
Level 1 —
|
Valuations based on unadjusted quoted prices in active markets for
identical assets or liabilities that the Company has the ability to access. Valuation adjustments and block discounts are not being applied. Since valuations are based on quoted prices that are readily and regularly available in an
active market, valuation of these securities does not entail a significant degree of judgment.
|
Level 2 —
|
Valuations based on (i) quoted prices in active markets for similar
assets and liabilities, (ii) quoted prices in markets that are not active for identical or similar assets, (iii) inputs other than quoted prices for the assets or liabilities, or (iv) inputs that are derived principally from or
corroborated by market through correlation or other means.
|
Level 3 —
|
Valuations based on inputs that are unobservable and significant to
the overall fair value measurement.
|
The following table presents information about the Company’s assets and
liabilities that are measured at fair value on a recurring basis at September 30, 2021, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:
September 30,
|
Quoted
Prices In
Active
Markets
|
Significant
Other
Observable
Inputs
|
Significant
Other
Unobservable
Inputs
|
|||||||||||||
2021
|
(Level 1)
|
(Level 2)
|
(Level 3)
|
|||||||||||||
Liabilities:
|
||||||||||||||||
Public Warrants Liability
|
$
|
7,546,875
|
$
|
7,546,875
|
$
|
—
|
$
|
—
|
||||||||
Private Placement Warrants Liability
|
5,425,000
|
—
|
5,425,000
|
—
|
||||||||||||
$
|
12,971,875
|
$
|
7,546,875
|
$
|
5,425,000
|
$
|
—
|
The Warrants are accounted for as liabilities in accordance with ASC 815-40 and
are presented within warrant liabilities on the Condensed Balance Sheet. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant
liabilities in the Condensed Statement of Operations.
The Company established the initial fair value of the Public Warrants and
Private Warrants on February 23, 2021, the date of the Company’s Initial Public Offering, using a Monte Carlo simulation model. The Warrants were classified as Level 3 at the initial measurement date due to the use of unobservable inputs. As of September 30, 2021, the Company used the quoted
market price as the fair value of the Public Warrants and the Public Warrants were reclassified from Level 3 to Level 1. Due to certain “make whole” provisions in the warrant agreement, the Company also used the quoted market price of the
Public Warrants as the fair value of the Private Warrants as of September 30, 2021, and reclassified the Private Warrants from Level 3 to Level 2.
The key inputs into the Monte Carlo simulation as of February 23, 2021 were as
follows:
Inputs
|
(Initial
Measurement)
February 23, 2021
|
|||
Risk-free interest rate
|
0.80
|
%
|
||
Expected term remaining (years)
|
6.0
|
|||
Expected term until Merger (years)
|
1.0
|
|||
Estimated probability of successful Merger
|
50.0
|
%
|
||
Expected volatility Pre-Merger
|
10.0
|
%
|
||
Expected volatility Post-Merger
|
50.0
|
%
|
||
Implied Stock price
|
$
|
10.86
|
||
Exercise price
|
$
|
11.50
|
The carrying value, excluding gross unrealized holding
loss and fair value of held to maturity securities on September 30, 2021 are as follows:
Carrying
Value as of
September 30, 2021
|
Gross
Unrealized
Gains
|
Gross
Unrealized
Losses
|
Fair Value
as of
September 30,
2021
|
|||||||||||||
U.S. Treasury Securities
|
$
|
287,522,646
|
$
|
-
|
$
|
499
|
$
|
287,523,145
|
||||||||
|
$
|
287,522,646
|
$
|
-
|
$
|
499
|
$
|
287,523,145
|
Note 10 — Subsequent Events
The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon
this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.
References to the “Company,” “Figure Acquisition Corp. I.,” “our,” “us” or “we” refer to Figure Acquisition Corp. I. The following discussion and analysis of the Company’s financial condition
and results of operations should be read in conjunction with the unaudited interim condensed financial statements and the notes thereto contained elsewhere in this report. Certain information contained in the discussion and analysis set forth
below includes forward-looking statements that involve risks and uncertainties.
Cautionary Note Regarding Forward-Looking Statements
This Quarterly Report on Form 10-Q includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act. We have
based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual
results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify
forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “continue,” or the negative of such terms or other similar expressions. Factors that might cause or
contribute to such a discrepancy include, but are not limited to, those described in our other SEC filings.
Overview
We are a blank check company incorporated in Delaware on December 15, 2020. We were formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar
business combination with one or more businesses (the “Business Combination”).
Our Sponsor is Fintech Acquisition LLC, a Delaware limited liability company. The registration statement for the Initial Public Offering was declared effective on February 18, 2021. On February 23, 2021, we
consummated the Initial Public Offering of 28,750,000 Units, at $10.00 per Unit, generating gross proceeds of $287.5 million, and incurring offering costs of approximately $16.3 million, inclusive of approximately $10.1 million in deferred
underwriting commissions.
Simultaneously with the closing of the Initial Public Offering, we consummated the Private Placement of 5,166,667 Private Placement Warrants, at a price of $1.50 per Private Placement Warrant to our Sponsor,
generating gross proceeds to us of approximately $7.75 million.
Upon the closing of the Initial Public Offering and the Private Placement, $287.5 million ($10.00 per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement
was placed in the Trust Account and was invested in permitted United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act of 1940, as amended, having a maturity of 185 days or less or in money market
funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act that invest only in direct U.S. government treasury obligations.
Our management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net
proceeds are intended to be applied generally toward consummating a Business Combination.
We will only have 24 months from the closing of the Initial Public Offering, or February 23, 2023, to complete our initial Business Combination (the “Combination Period”). If we do not complete a Business
Combination within this period of time, we will (i) cease all operations except for the purposes of winding up; (ii) as promptly as reasonably possible, but not more than ten business days thereafter, redeem the Public Shares for a per share pro
rata portion of the Trust Account, including interest and not previously released to us to fund our working capital requirements (subject to an annual limit of $500,000) (less taxes payable and up to $100,000 of such net interest to pay
dissolution expenses) and (iii) as promptly as possible following such redemption, dissolve and liquidate the balance of our net assets to our remaining stockholders, as part of our plan of dissolution and liquidation. Our Sponsor and our
executive officers and independent director nominees (the “initial stockholders”) entered into a letter agreement with us, pursuant to which they have waived their rights to participate in any redemption with respect to their Founder Shares;
however, if the initial stockholders or any of our officers, directors or affiliates acquire shares of common stock in or after the Initial Public Offering, they will be entitled to a pro rata share of the Trust Account upon our redemption or
liquidation in the event we do not complete a Business Combination within the required time period. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including
Trust Account assets) will be less than the Initial Public Offering price per Unit in the Initial Public Offering.
Results of Operations
For the nine months ended September 30, 2021, we had a net income of approximately $4.7 million, which included a loss from operations of $0.5
million, offering cost expense allocated to warrants of $0.6 million, and offset mainly by a gain from the change in fair value of warrant liabilities of $5.8 million.
Our business activities from inception to September 30, 2021 consisted primarily of our formation and completing our IPO, and since the offering, our activity has been limited to identifying and evaluating
prospective acquisition targets for a Business Combination.
Liquidity and Capital Resources
As of September 30, 2021, we had approximately $0.9 million in our operating bank account and working capital of approximately $1 million.
Prior to the completion of the Initial Public Offering, our liquidity needs have been satisfied through the cash receipt of $25,000 from our Sponsor in exchange for the issuance of the Founder Shares, and an up to
$300,000 note agreement issued to our Sponsor, which was repaid by us on February 25, 2021. Subsequent to the consummation of the Initial Public Offering and Private Placement, our liquidity needs have been satisfied with the proceeds from the
consummation of the Private Placement not held in the Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, our Sponsor may, but are not obligated to, provide us Working Capital Loans. To
date, there were no Working Capital Loans outstanding.
Based on the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation of a Business Combination or one
year from this filing. Over this time period, we will be using these funds to pay existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target
businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination.
Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that the specific impact is not readily determinable as of the date of the balance sheet. The financial statements do not
include any adjustments that might result from the outcome of this uncertainty.
Contractual Obligations
We do not have any long-term debt obligations, capital lease obligations, operating lease obligations, purchase obligations or long-term liabilities
Registration Rights
The initial stockholders and holders of the Private Placement Warrants will be entitled to registration rights pursuant to a registration rights agreement. The initial stockholders and holders of the Private
Placement Warrants will be entitled to make up to three demands, excluding short form registration demands, that register such securities for sale under the Securities Act. In addition, these holders will have “piggy-back” registration rights to
include their securities in other registration statements filed by us. We will bear the expenses incurred in connection with the filing of any such registration statements.
Underwriting Agreement
We agreed to pay the underwriters an additional fee (the “Deferred Underwriting Fees”) of 3.5% of the gross proceeds of the IPO, or $10,062,500 in the aggregate. The deferred fee will become payable to the
underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.
Critical Accounting Policies
This management’s discussion and analysis of our financial condition and results of operations is based on our unaudited condensed financial statements, which have been prepared in accordance
with U.S. GAAP. The preparation of these unaudited condensed financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingent assets
and liabilities in our unaudited condensed financial statements. On an ongoing basis, we evaluate our estimates and judgments, including those related to fair value of financial instruments and accrued expenses. We base our estimates on
historical experience, known trends and events and various other factors that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that
are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.
Except as set forth below, there have been no significant changes in our critical accounting policies as discussed in the final prospectus filed by us with the SEC on February 22, 2021.
Warrants Liability
We evaluated the Warrants in accordance with ASC 815-40, “Derivatives and Hedging — Contracts in Entity’s Own Equity”, and concluded that a provision in the Warrant Agreement related to certain
tender or exchange offers as well as provisions that provided for potential changes to the settlement amounts dependent upon the characteristics of the holder of the warrant, precludes the Warrants from being accounted for as components of
equity. As the Warrants meet the definition of a derivative as contemplated in ASC 815 and are not eligible for an exception from derivative accounting, the Warrants are recorded as derivative liabilities on the Balance Sheet and measured at fair
value at inception (on the date of the IPO) and at each reporting date in accordance with ASC 820, “Fair Value Measurement”, with changes in fair value recognized in the Statement of Operations in the period of change.
Common Stock Subject to Possible Redemption
All of the Class A Common Stock sold as part of the Units in the Public Offering contain a redemption feature which allows for the redemption of such public shares in
connection with the Company’s liquidation, if there is a stockholder vote or tender offer in connection with the Business Combination and in connection with certain amendments to the Company’s second amended and restated certificate of
incorporation. In accordance with SEC and its staff’s guidance on redeemable equity instruments, which has been codified in ASC 480-10-S99, redemption provisions not solely within the control of the Company require common stock subject to
redemption to be classified outside of permanent equity. Ordinary liquidation events, which involve the redemption and liquidation of all of the entity’s equity instruments, are excluded from the provisions of ASC 480. Accordingly, at September 30, 2021 and December 31, 2020, all shares of Class A common stock subject to possible redemption is presented as temporary equity, outside of the stockholders’ equity section of the
Company’s condensed balance sheet.
The Company recognizes changes in redemption value immediately as they occur and adjusts the carrying value of redeemable common stock to equal the redemption value at the end of each
reporting period. Increases or decreases in the carrying amount of redeemable common stock are affected by charges against additional paid in capital and accumulated deficit.
Net (Loss) Income Per Common Share
The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, Earnings Per Share. Net loss per share is computed by dividing net loss by the
weighted average number of shares of common stock outstanding during the period. The Company has two classes of shares, Class A Common Stock and Class B Common Stock. Earnings and losses are shared pro rata
between the two classes of shares. The Company has not considered the effect of warrants sold in the Initial Public Offering and the private placement to purchase 12,354,167 shares of common stock in
the calculation of diluted loss per share, since the exercise of the warrants is contingent upon the occurrence of future events. As a result, diluted net income per common share is the same as basic net income per ordinary share for the period
presented.
Basic and diluted net income per common share for Class A common stock and Class B common stock is calculated by dividing net income attributable to the Company by the weighted average number
of shares of Class A common stock and Class B common stock outstanding, allocated proportionally to each class of common stock.
Recent Accounting Pronouncements
Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.
Off-Balance Sheet Arrangements
As of September 30, 2021, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K.
Inflation
We do not believe that inflation had a material impact on our business, revenues or operating results during the period presented.
JOBS Act
The Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We qualify as an “emerging growth
company” and under the JOBS Act are allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new or revised accounting
standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies. As a result, the financial statements may not be
comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.
Additionally, we are in the process of evaluating the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, if, as an
“emerging growth company,” we choose to rely on such exemptions we may not be required to, among other things, (i) provide an auditor’s attestation report on our system of internal controls over financial reporting pursuant to Section 404, (ii)
provide all of the compensation disclosure that may be required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be adopted by the Public
Company Accounting Oversight Board regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements (auditor discussion and analysis) and (iv) disclose
certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of the CEO’s compensation to median employee compensation. These exemptions will apply for a period of five years
following the completion of our Initial Public Offering or until we are no longer an “emerging growth company,” whichever is earlier.
Item 3. |
Quantitative and Qualitative Disclosures About Market Risk.
|
We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item.
Item 4. |
Controls and Procedures.
|
Evaluation of Disclosure Controls and Procedures
Disclosure controls are procedures that are designed with the objective of ensuring that information required to be disclosed in our reports filed under the Exchange
Act, such as this report, is recorded, processed, summarized, and reported within the time period specified in the SEC’s rules and forms. Disclosure controls are also designed with the objective of ensuring that such information is accumulated
and communicated to management, including the principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.
Under the supervision and with the participation of our management, including our
principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the fiscal quarter ended September 30, 2021, as such term is defined in
Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based upon that evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were not effective as of September 30, 2021,
due to the previous material weakness in our internal control over financial reporting described in Item 4. Controls and Procedures included in our Quarterly Report on Form 10-Q as filed with the SEC on May 24, 2021, and due to the restatements
of our February 23, 2021, March 31, 2021, and June 30, 2021 financial statements (the "restatements") regarding the classification of redeemable Class A Shares, as described below, which combined, constitutes a material weakness in our internal
control over financial reporting. In light of this material weakness, we performed additional analysis as deemed necessary to ensure that our unaudited interim financial statements were prepared in accordance with U.S. generally accepted
accounting principles. Accordingly, management believes that the financial statements included in this Quarterly Report on Form 10-Q present fairly in all material respects our financial position, results of operations and cash flows for the
period presented.
Regarding the restatements to the March 31, 2021 and June 30, 2021 quarterly financial statements included in the Company's Form 10-Qs, as filed with the SEC on May 24,
2021 and August 13, 2021, respectively, as well as the Company's balance sheet included on the Company's Form 8-K, as filed with the SEC on March 1, 2021, and restated on the Form 10-Q filed with the SEC on May 24, 2021, certain redemption
provisions not solely within the control of the Company require common stock subject to redemption to be classified outside of permanent equity. The Company had previously classified a portion of the Class A common stock in permanent equity. The
Company restated its financial statements to classify all Class A common stock as temporary equity and any related impact.
It is noted that the non-cash adjustments to the financial statement do not impact the amounts previously reported for our cash and cash equivalents or total assets. In
light of this material weakness, we performed additional analysis as deemed necessary to ensure that our unaudited interim financial statements were prepared in accordance with U.S. generally accepted accounting principles.
Changes in Internal Control over Financial Reporting
There was no change in our internal control over financial reporting that occurred
during the fiscal quarter ended September 30, 2021 covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
To respond to the material weakness described above, we have devoted, and plan to continue to devote, significant effort and resources to the
remediation and improvement of our internal control over financial reporting. While we have processes to identify and appropriately apply applicable accounting requirements, we plan to enhance our system of evaluating and implementing the
complex accounting standards that apply to our financial statements. Our plans at this time include providing enhanced access to accounting literature, research materials and documents and increased communication among our personnel and
third-party professionals with whom we consult regarding complex accounting applications. The elements of our remediation plan can only be accomplished over time, and we can offer no assurance that these initiatives will ultimately have the
intended effects.
Item 1. |
Legal Proceedings.
|
None.
Item 1A. |
Risk Factors.
|
Except as set forth below, as of the date of this Quarterly Report, there have been no material changes with respect to those risk factors
previously disclosed in our final prospectus relating to the Initial Public Offering dated February 18, 2021 filed with the SEC on February 22, 2021 or disclosed in the subsequent Quarterly Reports for the three and six months ended March 31,
2021 and June 30, 2021. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial
may also impair our business or results of operations.
Item 2. |
Unregistered Sales of Equity Securities and Use of Proceeds.
|
In December 2020, our Sponsor purchased 4,107,143 shares of Class B common stock and 8,214,286 shares of Class L common stock for a capital contribution of $25,000, or approximately $0.002 per share. In January
2021, the sponsor surrendered its Class B and Class L shares, and we reissued to the sponsor 3,194,444 shares of Class B common stock and 9,126,984 shares of Class L common stock, with no return of capital or payment by the sponsor, resulting in
the sponsor holding 3,194,444 shares of Class B common stock and 9,126,984 shares of Class L common stock with an effective purchase price of approximately $0.002 per share. In February, 2021, our sponsor transferred 20,000 shares of Class B
common stock to each of our independent directors. Prior to the initial investment in the company of $25,000 by our Sponsor, the Company had no assets, tangible or intangible. The per share price was determined by dividing the amount of cash
contributed to the company by the number of founder shares issued.
Our Sponsor is an accredited investor for purposes of Rule 501 of Regulation D. Each of the equity holders in our Sponsor is an accredited investor under Rule 501 of Regulation D. The sole business of our Sponsor
is to act as the Company’s sponsor in connection with this offering. The limited liability company agreement of our Sponsor provides that its membership interests may only be transferred to our officers or directors or other persons affiliated
with our Sponsor, or in connection with estate planning transfers.
Simultaneously with the closing of our Initial Public Offering, pursuant to the Private Placement Warrants Purchase Agreement, the Company completed the private sale of an aggregate of 5,166,667 warrants (the
“Private Placement Warrants”) to our Sponsor at a purchase price of $1.50 per Private Placement Warrant, generating gross proceeds to the Company of $7,750,000. The Private Placement Warrants are identical to the Warrants sold in the Initial
Public Offering, except that the Private Placement Warrants, so long as they are held by our Sponsor or its permitted transferees, (i) are not redeemable by the Company, (ii) may not (including the Class A common stock issuable upon exercise of
such Private Placement Warrants), subject to certain limited exceptions, be transferred, assigned or sold by such holders until 30 days after the completion of the Company’s initial business combination, (iii) may be exercised by the holders on a
cashless basis and (iv) will be entitled to registration rights. No underwriting discounts or commissions were paid with respect to such sale. The issuance of the Private Placement Warrants was made pursuant to the exemption from registration
contained in Section 4(a)(2) of the Securities Act of 1933, as amended.
Item 3. |
Defaults upon Senior Securities.
|
None.
Item 4. |
Mine Safety Disclosures.
|
Not applicable.
Item 5. |
Other Information.
|
None.
Exhibit
Number
|
Description
|
|
Certification of Chief Executive Officer (Principal Executive Officer) Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002.
|
||
Certification of Chief Financial Officer (Principal Financial and Accounting Officer) Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302
of the Sarbanes-Oxley Act of 2002.
|
||
Certification of Chief Executive Officer (Principal Executive Officer) Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
||
Certification of Chief Financial Officer (Principal Financial and Accounting Officer) Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
||
101.INS
|
XBRL Instance Document
|
|
101.SCH
|
XBRL Taxonomy Extension Schema Document
|
|
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
101.LAB
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
*
|
Filed herewith.
|
**
|
These certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as
amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.
|
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
By:
|
/s/ Thomas J. Milani
|
||
Name:
|
Thomas J. Milani
|
||
Title:
|
Chief Financial Officer
|
||
Dated: November 22, 2021
|
25